T1	Organism 577 585	patients
T2	Organism 599 604	human
T3	Organism 614 636	Pseudomonas aeruginosa
T4	Organism 693 701	patients
T5	Organism 799 812	P. aeruginosa
T6	Organism 1178 1183	human
T7	Organism 1425 1438	P. aeruginosa
T8	Protein 2210 2214	MvaT
T9	Organism 2218 2231	P. aeruginosa
T10	Protein 2334 2338	MvaT
T11	Organism 2400 2412	type IV pili
T12	Organism 2417 2442	flagella deletion mutants
T13	Chemical 2629 2682	bis-(3'-5')-cyclic diguanylic guanosine monophosphate
T14	Chemical 2684 2697	cyclic-di-GMP
T15	Organism 2767 2786	Acetobacter xylinum
T16	Organism 3030 3043	P. aeruginosa
T17	Chemical 3100 3113	cyclic-di-GMP
T18	Protein 3263 3267	BifA
T19	Protein 3318 3322	SadC
T20	Protein 3351 3355	SadB
T21	Chemical 3408 3421	cyclic-di-GMP
T22	Protein 3446 3449	Pel
T23	Protein 3454 3457	Psl
T24	Organism 3490 3503	P. aeruginosa
T25	Protein 3574 3577	Pel
T26	Protein 3582 3585	Psl
T27	Protein 3750 3753	pel
T28	Protein 3758 3761	psl
T29	Protein 3807 3811	RetS
T30	Protein 4008 4012	RetS
T31	Protein 4235 4239	RetS
T32	Protein 4333 4337	GacS
T33	Protein 4342 4346	LadS
T34	Organism 4487 4500	P. aeruginosa
T35	Protein 4530 4534	rsmZ
T36	Protein 4562 4566	RetS
T37	Protein 4674 4678	LadS
T38	Protein 4683 4687	GacS
T39	Organism 4885 4898	P. aeruginosa
T40	Two-component-system 4965 4974	GacA/GacS
T41	Protein 4965 4969	GacA
T42	Protein 4970 4974	GacS
T43	Organism 5643 5656	P. aeruginosa
T44	Two-component-system 5846 5851	BfiRS
T45	Protein 5846 5850	BfiR
T46	Protein 5850 5851	S
T47	Protein 5853 5859	PA4196
T48	Protein 5860 5864	4197
T49	Two-component-system 5867 5872	BfmRS
T50	Protein 5867 5871	BfmR
T51	Protein 5871 5872	S
T52	Protein 5874 5880	PA4101
T53	Protein 5881 5885	4102
T54	Two-component-system 5892 5897	MifRS
T55	Protein 5892 5896	MifR
T56	Protein 5896 5897	S
T57	Protein 5899 5905	PA5511
T58	Protein 5906 5910	5512
T59	Organism 5983 5996	P. aeruginosa
T60	Organism 6149 6162	P. aeruginosa
T61	Two-component-system 6326 6331	BfiRS
T62	Protein 6326 6330	BfiR
T63	Protein 6330 6331	S
T64	Two-component-system 6354 6359	BfmRS
T65	Protein 6354 6358	BfmR
T66	Protein 6358 6359	S
T67	Two-component-system 6389 6394	MifRS
T68	Protein 6389 6393	MifR
T69	Protein 6393 6394	S
*	Equiv T13 T14
T70	Process 513 523	infections
T71	Process 542 552	infections
T72	Process 872 882	infections
T73	Process 1144 1154	resistance
T74	Regulation 3091 3099	modulate
T75	Positive_regulation 3422 3431	dependent
T76	Regulation 3432 3442	regulation
T77	Gene_expression 3732 3742	Expression
T78	Regulation 3771 3782	coordinated
T79	Process 3918 3927	virulence
T80	Process 3992 4001	infection
T81	Negative_regulation 4546 4558	Inactivation
T82	Negative_regulation 4653 4665	inactivation
T83	Positive_regulation 4688 4695	results
T84	Positive_regulation 4699 4708	increased
T85	Process 4709 4718	virulence
E1	Process:T70 
E2	Process:T71 
E3	Process:T72 Participant:T5
E4	Process:T73 
E5	Regulation:T74 Theme:T17
E6	Positive_regulation:T75 Theme:E8 Cause:T21
E7	Positive_regulation:T75 Theme:E9 Cause:T21
E8	Regulation:T76 Theme:T22
E9	Regulation:T76 Theme:T23
E10	Gene_expression:T77 Theme:T28
E11	Gene_expression:T77 Theme:T27
E12	Regulation:T78 Theme:E11 Cause:T29
E13	Regulation:T78 Theme:E10 Cause:T29
E14	Process:T79 
E15	Process:T80 
E16	Negative_regulation:T81 Theme:T36
E17	Negative_regulation:T82 Theme:T37
E18	Negative_regulation:T82 Theme:T38
E19	Positive_regulation:T83 Theme:E21 Cause:E17
E20	Positive_regulation:T83 Theme:E21 Cause:E18
E21	Positive_regulation:T84 Theme:E22
E22	Process:T85 
T86	Span 799 882	P. aeruginosa causes a variety of diseases in individuals predisposed to infections
T87	Causality 883 899	as the result of
E23	Causality:T87 Effect:T88 Evidence:T86
T88	Span 900 982	severe burns, wounds, urinary tract or corneal injury, or immunocompromised status
T89	Span 992 1091	Biofilm cells differ from their planktonic counterparts in the genes and proteins that they express
T90	Causality 1093 1105	resulting in
E24	Causality:T90 Effect:T91 Evidence:T89
T91	Span 1106 1197	distinct phenotypes including altered resistance to antibiotics and the human immune system
T92	Span 1218 1342	it is not surprising that biofilms are considered to be differentiated communities compared to their planktonic counterparts
T94	Span 1391 1514	various microorganisms, including P. aeruginosa have been shown to form biofilms in a stage-specific and coordinated manner
T93	Causality 1353 1390	This is supported by the finding that
E25	Causality:T93 Effect:T92 Evidence:T94
T95	Span 2400 2471	type IV pili and flagella deletion mutants exhibited reduced attachment
T96	Causality 2472 2487	indicating that
E26	Causality:T96 Effect:T97 Evidence:T95
T97	Span 2488 2561	attachment and biofilm formation are mediated by extracellular appendages
T98	Span 2592 2875	the intracellular signaling molecule bis-(3'-5')-cyclic diguanylic guanosine monophosphate (cyclic-di-GMP), first described to control extracellular cellulose biosynthesis in Acetobacter xylinum [18],[19], has been demonstrated in several microorganisms to modulate biofilm formation
T99	Causality 2876 2879	via
E27	Causality:T99 Effect:T100 Evidence:T98
T100	Span 2880 3015	the production of exopolysaccharides or matrix components, control auto-aggregation of planktonic cells, and regulate swarming motility
T101	Span 4546 4759	Inactivation of RetS results in reduced cytotoxicity but increased attachment and biofilm formation, while inactivation of both LadS and GacS results in increased virulence but decreased biofilm formation capacity
T102	Causality 4771 4803	This multi-component switch thus
E28	Causality:T102 Effect:T103 Evidence:T101
T103	Span 4804 4974	orchestrates the transition from the planktonic to the biofilm mode of growth by P. aeruginosa via phosphorylation events of the two-component regulatory system GacA/GacS
